These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11599688)

  • 21. Comparison of the effect of two different doses of recombinant hepatitis B vaccine on immunogenicity in healthy adults.
    Li J; Yao J; Shan H; Chen Y; Jiang ZG; Ren JJ; Xu KJ; Ruan B; Yang SG; Wang B; Xie TS; Li Q
    Hum Vaccin Immunother; 2015; 11(5):1108-13. PubMed ID: 25607773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-HBs levels in infants of hepatitis B carrier mothers after delayed active immunization with recombinant vaccine concomitant with DTP-polio vaccine: is there need for a second dose of HBIg? Dutch Study Group on Prevention of Neonatal Hepatitis B.
    Grosheide PM; del Canho R; Voogd M; Heijtink RA; Schalm SW
    Vaccine; 1994 Sep; 12(12):1059-63. PubMed ID: 7998413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of immunogenicity and reactogenicity of recombinant DNA hepatitis B vaccine produced in India.
    Hussain Z; Ali SS; Husain SA; Raish M; Sharma DR; Kar P
    World J Gastroenterol; 2005 Dec; 11(45):7165-8. PubMed ID: 16437665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
    Salama II; Sami SM; Salama SI; Foud WA; Abdel Hamid AT; Said ZN
    Egypt J Immunol; 2014; 21(1):13-26. PubMed ID: 25204041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors].
    Chlíbek R; Smetana J; Sindelár R; Cecetková B; Prymula R; Kohl I
    Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):119-28. PubMed ID: 17900060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative long term immunogenicity of two recombinant hepatitis B vaccines and the effect of a booster dose given after five years in a low endemicity country.
    Duval B; Gîlca V; Boulianne N; De Wals P; Massé R; Trudeau G; De Serres G
    Pediatr Infect Dis J; 2005 Mar; 24(3):213-8. PubMed ID: 15750456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity of a recombinant Pre-S2-containing hepatitis B vaccine versus plasma-derived vaccine administered as a booster.
    Bucher B; Francioli P; Geudelin B; Fritzell B; Lavanchy D; Frei PC
    Eur J Clin Microbiol Infect Dis; 1994 Mar; 13(3):212-7. PubMed ID: 8050433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brazilian hepatitis B vaccine: a six-year follow-up in adolescents.
    Alexandre KV; Martins RM; Souza MM; Rodrigues IM; Teles SA
    Mem Inst Oswaldo Cruz; 2012 Dec; 107(8):1060-3. PubMed ID: 23295759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and immunogenicity of a combined hepatitis B virus-Haemophilus influenzae type B vaccine comprising a synthetic antigen in healthy adults.
    Aguilar-Betancourt A; González-Delgado CA; Cinza-Estévez Z; Martínez-Cabrera J; Véliz-Ríos G; Alemán-Zaldívar R; Alonso-Martínez MI; Lago-Baños M; Puble-Alvarez N; Delahanty-Fernandez A; Juvier-Madrazo AI; Ortega-León D; Olivera-Ruano L; Correa-Fernández A; Abreu-Reyes D; Soto-Mestre E; Pérez-Pérez MV; Figueroa-Baile N; Pérez LH; Rodríguez-Silva A; Martínez-Díaz E; Guillén-Nieto GE; Muzio-González VL
    Hum Vaccin; 2008; 4(1):54-9. PubMed ID: 18441530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Presence of maternal anti-HBs antibodies does not influence hepatitis B vaccine response in Brazilian neonates.
    Junqueira AL; Tavares VR; Martins RM; Frauzino KV; Silva AM; Rodrigues IM; Minamisava R; Teles SA
    Mem Inst Oswaldo Cruz; 2011 Feb; 106(1):113-6. PubMed ID: 21340365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune response to hepatitis B vaccination in HIV-positive adults with isolated antibodies to HBV core antigen.
    Kaech C; Pache I; Bürgisser P; Elzi L; Darling KE; Cavassini M
    J Infect; 2012 Aug; 65(2):157-64. PubMed ID: 22410383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study.
    Zanetti AR; Mariano A; Romanò L; D'Amelio R; Chironna M; Coppola RC; Cuccia M; Mangione R; Marrone F; Negrone FS; Parlato A; Zamparo E; Zotti C; Stroffolini T; Mele A;
    Lancet; 2005 Oct 15-21; 366(9494):1379-84. PubMed ID: 16226616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of two recombinant hepatitis B vaccines and their interchangeability in Argentine infants.
    Tregnaghi M; Ussher J; Baudagna AM; Calvari M; Graña G
    Rev Panam Salud Publica; 2004 Jan; 15(1):35-40. PubMed ID: 14987456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intradermal recombinant hepatitis B vaccination (IDRV) for non-responsive healthcare workers (HCWs).
    Ghebrehewet S; Baxter D; Falconer M; Paver K
    Hum Vaccin; 2008; 4(4):280-5. PubMed ID: 18398298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity of a recombinant hepatitis B vaccine in haemodialysis patients.
    Bruguera M; Cremades M; Mayor A; Sánchez Tapias JM; Rodés J
    Postgrad Med J; 1987; 63 Suppl 2():155-8. PubMed ID: 3317354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China.
    Wang ZZ; Gao YH; Lu W; Jin CD; Zeng Y; Yan L; Ding F; Li T; Liu XE; Zhuang H
    Hum Vaccin Immunother; 2017 Apr; 13(4):909-915. PubMed ID: 27874311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Study on the immuno-effects and influencing factors of Chinese hamster ovary (CHO) cell hepatitis B vaccine among adults, under different dosages].
    Zhang W; Lin CY; Han LL; Li LQ; Gao P; Lin H; Gong XH; Huang F; Tang YQ; Ma JX; Zhang HY; Wang C; Yang P; Li H; Sun MP; He X; Pang XH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Jul; 31(7):767-70. PubMed ID: 21162840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative efficacy of two dosages of recombinant hepatitis B vaccine in healthy adolescents in India.
    Velu V; Nandakumar S; Shanmugam S; Shankar EM; Thangavel S; Kulkarni PS; Thyagarajan SP
    Pediatr Infect Dis J; 2007 Nov; 26(11):1038-41. PubMed ID: 17984812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune response after hepatitis A vaccination in haemodialysis patients: comparison with hepatitis B vaccination.
    Kuramoto I; Fujiyama S; Matsushita K; Sato T
    J Gastroenterol Hepatol; 1994; 9(3):228-31. PubMed ID: 8054520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the response to a booster dose of hepatitis B vaccine in previously immunized healthcare workers.
    Williams JL; Christensen CJ; McMahon BJ; Bulkow LR; Cagle HH; Mayers JS; Zanis CL; Parkinson AJ; Margolis HS
    Vaccine; 2001 Jul; 19(28-29):4081-5. PubMed ID: 11427285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.